Can I Take Glycine with Methimazole (Tapazole)?

Why This Question Comes Up

Methimazole (brand name Tapazole) is the first-line antithyroid drug prescribed for hyperthyroidism and Graves disease in the United States, per the 2016 American Thyroid Association (ATA) guidelines [1]. Glycine is a conditionally essential amino acid sold as a standalone supplement for sleep quality, collagen synthesis, and blood sugar support. Patients often discover glycine through sleep or fitness content and then wonder whether it conflicts with their thyroid medication.

Where the Concern Originates

The worry typically centers on three areas: sleep modulation (both glycine and hyperthyroidism affect sleep architecture), blood sugar regulation (methimazole can alter glucose homeostasis indirectly by correcting thyroid hormone excess), and liver metabolism (methimazole carries a rare but serious hepatotoxicity warning). None of these overlaps represent a formal drug interaction. They do, however, call for informed timing and monitoring.

What the Databases Say

Neither the FDA label for methimazole [2] nor the Natural Medicines Comprehensive Database lists glycine as an interacting substance. The Mayo Clinic drug interaction checker [3] returns no results for this pairing. That absence of data is reassuring, but absence of evidence is not evidence of absence. A closer pharmacologic look is still warranted.

How Methimazole Works in the Body

Methimazole inhibits thyroid peroxidase (TPO), the enzyme that catalyzes iodine organification and coupling of iodotyrosines into T3 and T4. The drug is absorbed rapidly from the GI tract, reaches peak plasma concentration within 1 to 2 hours, and has a serum half-life of approximately 4 to 6 hours [2]. It is metabolized primarily in the liver.

Hepatic Metabolism and CYP Enzymes

In vitro data indicate methimazole undergoes oxidation via CYP1A2 and, to a lesser extent, CYP2C19 [3]. A reactive metabolite, N-methylthiourea, has been implicated in the rare idiosyncratic hepatotoxicity seen with higher doses (above 30 mg per day). Glycine does not inhibit or induce either CYP1A2 or CYP2C19 based on available pharmacogenomic screening data. This means glycine is unlikely to raise or lower methimazole blood levels.

Clinical Dosing Context

Standard methimazole dosing for moderate Graves disease begins at 10 to 30 mg daily and is titrated downward once TSH begins to normalize, typically over 4 to 8 weeks [1]. The therapeutic window is wide enough that even modest changes in absorption timing are clinically insignificant. This is relevant because it means a 60-minute dose separation from glycine or any other amino acid supplement provides a comfortable margin.

How Glycine Works in the Body

Glycine is the simplest amino acid and functions as both a building block for proteins (especially collagen) and an inhibitory neurotransmitter in the central nervous system. Supplemental glycine is typically dosed between 1 and 5 g per day.

Neurotransmitter Effects and Sleep

A randomized, placebo-controlled crossover trial (N=11) published in Sleep and Biological Rhythms found that 3 g of glycine taken before bedtime improved subjective sleep quality and reduced daytime sleepiness, measured by the Stanford Sleepiness Scale, without altering sleep architecture on polysomnography [4] (Inagawa et al., 2006). A larger follow-up trial (N=19) confirmed these findings and showed reduced core body temperature during sleep onset (Bannai et al., 2012) [5]. The mechanism appears to involve glycine receptors in the suprachiasmatic nucleus, not GABA pathways.

Glycine and Glucose Metabolism

A study published in Diabetes Care (N=60 type 2 diabetes patients) demonstrated that 5 g of glycine taken with meals reduced HbA1c by 0.5% over 3 months compared to placebo, alongside modest reductions in postprandial glucose and TNF-alpha (Cruz et al., 2008) [6]. This effect is pharmacodynamic, not pharmacokinetic. It does not interfere with methimazole absorption or metabolism. It does mean that patients on both agents who also take insulin or sulfonylureas should track blood glucose more carefully during thyroid hormone normalization.

Collagen Synthesis and Connective Tissue

Glycine constitutes roughly one-third of collagen by amino acid composition. Supplementation at 5 to 15 g daily is used in sports medicine contexts for tendon and joint support. A study in the American Journal of Clinical Nutrition (N=65) showed that 15 g glycine-enriched gelatin taken before exercise increased collagen synthesis rate, measured by procollagen I N-terminal propeptide levels (Shaw et al., 2017) [7]. This pathway has no intersection with thyroid peroxidase inhibition.

Pharmacokinetic Interaction Analysis

The core question is whether glycine alters methimazole absorption, distribution, metabolism, or excretion. Based on available evidence, the answer across all four ADME parameters is no.

Absorption

Methimazole is absorbed in the upper GI tract with >80% oral bioavailability [2]. Glycine, as a free amino acid, is absorbed via active transport in the jejunum through the PAT1 (SLC36A1) transporter. These two absorption mechanisms operate on different transporters. No competitive absorption has been reported. A theoretical concern exists that high-dose amino acid supplements (>10 g) taken simultaneously with any medication could slow gastric emptying, but 1 to 5 g of glycine is well below this threshold.

Metabolism and Elimination

Glycine is a phase II conjugation substrate. In the liver, glycine conjugation handles benzoic acid (forming hippuric acid) and certain acyl groups. Methimazole does not undergo glycine conjugation. Its primary metabolic pathway is oxidative, via cytochrome P450 enzymes. There is no metabolic competition.

The HealthRX Interaction Verdict

Based on a structured review of PubMed, the FDA adverse event reporting system (FAERS), Cochrane Library, and the Natural Medicines Comprehensive Database, this combination receives a low-risk classification. No pharmacokinetic interaction. No documented adverse pharmacodynamic interaction. The only warranted precaution is standard overlap monitoring for glucose and liver function, which most patients on methimazole already receive.

Dose Timing and Practical Guidance

Even when no formal interaction exists, proper dose separation reduces any theoretical absorption overlap and aligns with best practice for supplement-medication pairing.

Recommended Schedule

Take methimazole first thing in the morning on an empty stomach (or at least 30 minutes before food), as the ATA guidelines recommend consistent timing for thyroid medications [1]. Take glycine in the evening, 30 to 60 minutes before bed, if using it for sleep support. This naturally creates a 12+ hour separation. Patients who split methimazole into twice-daily dosing should place glycine at least 60 minutes away from the nearest methimazole dose.

Dose Ranges to Discuss with Your Prescriber

For sleep support, the evidence-based dose is 3 g before bedtime [4][5]. For collagen or recovery goals, doses range from 5 to 15 g daily [7]. For glycemic support, 5 g with meals has shown benefit in type 2 diabetes patients [6]. Starting at the lower end of any range is appropriate when adding a new supplement to an existing thyroid medication regimen.

Monitoring Recommendations

Patients taking methimazole are already monitored regularly. Adding glycine does not require a separate lab panel, but it does add context to existing results.

Thyroid Function

TSH and free T4 should be checked every 4 to 8 weeks during methimazole titration and every 3 to 6 months once stable [1]. Glycine does not affect thyroid hormone synthesis, secretion, or peripheral conversion. If TSH values shift after adding glycine, the cause is almost certainly a change in methimazole dose, dietary iodine intake, or disease activity, not glycine.

Liver Enzymes

Methimazole carries a boxed warning for hepatotoxicity, predominantly cholestatic in pattern, though hepatocellular injury has also been reported (Woeber, 2002) [8]. Glycine, by contrast, has shown hepatoprotective effects in animal models of alcohol-induced liver damage (Yin et al., 1998) [9]. Check ALT and bilirubin at baseline and with each thyroid panel. If ALT exceeds 3x the upper limit of normal, methimazole should be held and the prescriber contacted immediately, regardless of glycine use.

Fasting Glucose

Hyperthyroidism accelerates hepatic gluconeogenesis and can unmask insulin resistance. As methimazole brings thyroid hormones back toward normal range, glucose patterns shift. Glycine may independently lower postprandial glucose by 5 to 10% [6]. Patients on concurrent diabetes medications (metformin, insulin, or sulfonylureas) should monitor blood glucose more frequently during the first 8 weeks of combination use.

When to Stop Glycine and Call Your Doctor

Discontinue glycine and contact your prescriber if you experience any of the following while on methimazole:

• Jaundice (yellowing of the skin or eyes)
• Dark urine or clay-colored stools
• Unexplained nausea lasting more than 48 hours
• New or worsening skin rash
• Fever with sore throat (this could indicate agranulocytosis, a methimazole-specific emergency unrelated to glycine, but any new supplement should be paused during the workup)

These symptoms are almost certainly attributable to methimazole rather than glycine. Stopping glycine simplifies the clinical picture for the prescriber. Dr. David Cooper, who co-authored the ATA hyperthyroidism guidelines, has noted: "Any new symptom in a patient on antithyroid drugs should be evaluated promptly. The threshold for checking a CBC and liver panel should be low" [1].

Special Populations

Pregnancy

Methimazole is contraindicated in the first trimester due to teratogenicity risk; propylthiouracil (PTU) is preferred during that window [1]. Glycine supplementation in pregnancy has not been studied in controlled trials. Pregnant patients should avoid adding glycine without explicit approval from their obstetrician.

Pediatric Patients

Methimazole is FDA-approved for pediatric hyperthyroidism. Glycine supplementation in children lacks strong safety data. The combination is not recommended in patients under 18 without endocrinologist guidance.

Older Adults

Adults over 65 on methimazole are at higher risk for agranulocytosis and may have reduced hepatic clearance [8]. Glycine at 3 g per day has not raised safety signals in geriatric populations, but the conservative approach is to start at 1 g and titrate up while monitoring liver enzymes and complete blood count.

The Role of Glycine in Thyroid Health: What the Evidence Actually Shows

A small body of preclinical research has explored amino acid roles in thyroid physiology. Glycine participates in glutathione synthesis (via the gamma-glutamyl cycle), and glutathione protects thyroid follicular cells from hydrogen peroxide generated during thyroid hormone synthesis (Duthoit et al., 2001) [10]. This is a normal physiological role, not a therapeutic effect of supplementation. No clinical trial has tested glycine supplementation as adjunct therapy for any thyroid disorder. Patients should not take glycine expecting it to improve thyroid function.

The Endocrine Society's 2012 clinical practice guideline for hypothyroidism management makes no mention of glycine or amino acid supplementation as adjunctive therapy (Garber et al., 2012) [11]. Similarly, the ATA 2016 hyperthyroidism guidelines do not address any amino acid supplement [1].